Company profile: Avivia
1.1 - Company Overview
Company description
- Provider of pharmaceutical CRO services, including analytical testing, drug formulation, generic drugs, repurposing, and troubleshooting.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avivia
Paloma Pharmaceuticals
HQ: United States
Website
- Description: Provider of early-stage drug development focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway, including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), and CNS (epilepsy and neurodegenerative).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paloma Pharmaceuticals company profile →
Merck
HQ: Germany
Website
- Description: Provider of life science, healthcare, and electronics solutions in the U.S. and Canada as EMD Serono, MilliporeSigma, and EMD Electronics. Supplies lab chemicals, solvents, materials, and tools; process solutions for drug development; end-to-end testing, analytics, and manufacturing support; develops medicines and devices for cancer, multiple sclerosis, fertility, and endocrine disorders; and materials/equipment for semiconductors, displays, and surfaces.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Merck company profile →
Bliss Biopharma
HQ: China
Website
- Description: Provider of tumor-targeting and immunotherapy therapeutics, focused on antibody-drug conjugates (ADCs). Offers BB-1701, an anti-HER2 ADC in international multi-center trials for HER2-positive solid tumors, and a diverse ADC pipeline in preclinical and clinical stages. Operates in-house, GMP-compliant antibody and ADC manufacturing to support clinical development and early commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bliss Biopharma company profile →
NovaTarg
HQ: United States
Website
- Description: Provider of tissue-targeted medicine discovery and cancer treatment programs. NovaTarg Therapeutics is a privately owned pharmaceutical company with a leadership team experienced in drug discovery and a novel approach to the discovery of tissue-targeted medicines; offerings include NT1195, a treatment program aimed at addressing cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NovaTarg company profile →
LP Pharmaceuticals
HQ: China
Website
- Description: Provider of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LP Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avivia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avivia
2.2 - Growth funds investing in similar companies to Avivia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avivia
4.2 - Public trading comparable groups for Avivia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →